Sign in
4

Changes in Ownership

BIOXYTRAN, INC Filed Acc 0001754429-24-000004

CEO bought 1,592,921 shares at $0.12 ($197,522)

  • CEO acquired 13,799,720 shares (other)
  • CEO disposed of 65,114,513 shares (other)
  • CEO acquired 8,973,405 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

PLATT DAVID · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-15 Purchase : show line 1 in the form +1,592,921 $0.12 $197,522 21,675,939 I
2024-08-19 Other disposition : show line 2 in the form −21,675,939 $0.16 $3,511,502 0 I
2024-08-19 Other acquisition : show line 3 in the form +4,335,188 $0.81 $3,494,162 4,335,188 I
2024-08-19 Conversion : show line 4 in the form +8,973,405 $0.02 $161,521 13,308,593 I
2024-08-19 Other acquisition : show line 5 in the form +776,817 $0.46 $354,229 14,085,410 I
2024-08-19 Other disposition : show line 6 in the form −411,300 $0.00 $411 0 I
2024-08-19 Other acquisition : show line 7 in the form +82,260 $0.01 $411 82,260 I
2024-08-19 Other disposition : show line 8 in the form −43,027,274 $0.00 $43,027 0 D
2024-08-19 Other acquisition : show line 9 in the form +8,605,455 $0.01 $43,027 8,605,455 D
Open-market purchases · 1,592,921 sh · avg $0.12 · $197,522
Loading xslF345X05/primary_doc.xml…